Real‐World Associations Between Renin‐Angiotensin‐Aldosterone System Inhibition Therapy, Hyperkalemia, and Outcomes: A Clinical and Scientific Call to Action

Bibliographic Details
Main Authors: Arlene Chapman, Samantha Gunning
Format: Article
Language:English
Published: Wiley 2019-11-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.119.014845
_version_ 1811275144290631680
author Arlene Chapman
Samantha Gunning
author_facet Arlene Chapman
Samantha Gunning
author_sort Arlene Chapman
collection DOAJ
first_indexed 2024-04-12T23:32:50Z
format Article
id doaj.art-863b46531f324a408b99a4d15ce558d8
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-04-12T23:32:50Z
publishDate 2019-11-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-863b46531f324a408b99a4d15ce558d82022-12-22T03:12:14ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802019-11-0182210.1161/JAHA.119.014845Real‐World Associations Between Renin‐Angiotensin‐Aldosterone System Inhibition Therapy, Hyperkalemia, and Outcomes: A Clinical and Scientific Call to ActionArlene Chapman0Samantha Gunning1University of Chicago Medicine Chicago ILUniversity of Chicago Medicine Chicago ILhttps://www.ahajournals.org/doi/10.1161/JAHA.119.014845Editorialschronic heart failurechronic kidney diseasehyperkalemiarenin‐angiotensin system
spellingShingle Arlene Chapman
Samantha Gunning
Real‐World Associations Between Renin‐Angiotensin‐Aldosterone System Inhibition Therapy, Hyperkalemia, and Outcomes: A Clinical and Scientific Call to Action
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Editorials
chronic heart failure
chronic kidney disease
hyperkalemia
renin‐angiotensin system
title Real‐World Associations Between Renin‐Angiotensin‐Aldosterone System Inhibition Therapy, Hyperkalemia, and Outcomes: A Clinical and Scientific Call to Action
title_full Real‐World Associations Between Renin‐Angiotensin‐Aldosterone System Inhibition Therapy, Hyperkalemia, and Outcomes: A Clinical and Scientific Call to Action
title_fullStr Real‐World Associations Between Renin‐Angiotensin‐Aldosterone System Inhibition Therapy, Hyperkalemia, and Outcomes: A Clinical and Scientific Call to Action
title_full_unstemmed Real‐World Associations Between Renin‐Angiotensin‐Aldosterone System Inhibition Therapy, Hyperkalemia, and Outcomes: A Clinical and Scientific Call to Action
title_short Real‐World Associations Between Renin‐Angiotensin‐Aldosterone System Inhibition Therapy, Hyperkalemia, and Outcomes: A Clinical and Scientific Call to Action
title_sort real world associations between renin angiotensin aldosterone system inhibition therapy hyperkalemia and outcomes a clinical and scientific call to action
topic Editorials
chronic heart failure
chronic kidney disease
hyperkalemia
renin‐angiotensin system
url https://www.ahajournals.org/doi/10.1161/JAHA.119.014845
work_keys_str_mv AT arlenechapman realworldassociationsbetweenreninangiotensinaldosteronesysteminhibitiontherapyhyperkalemiaandoutcomesaclinicalandscientificcalltoaction
AT samanthagunning realworldassociationsbetweenreninangiotensinaldosteronesysteminhibitiontherapyhyperkalemiaandoutcomesaclinicalandscientificcalltoaction